Melding	O
a	O
High	O
-	O
Risk	O
Patient	O
for	O
Continuous	B:C0181598
Flow	I:C0181598
Left	I:C0181598
Ventricular	I:C0181598
Assist	I:C0181598
Device	I:C0181598
into	O
a	O
Low	O
-	O
Risk	O
Patient	O
.	O

The	O
model	B:C3826979
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	O
of	O
mortality	O
after	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	O
.	O

The	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	B:C3826979
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	O
of	O
mortality	O
after	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	O
.	O

The	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	B:C0683956
of	O
mortality	O
after	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	O
.	O

The	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	O
of	O
mortality	O
after	O
left	B:C0181598
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	O
.	O

The	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	O
of	O
mortality	O
after	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	B:C0181598
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	O
.	O

The	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
(	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
)	O
has	O
been	O
used	O
as	O
a	O
predictor	O
of	O
mortality	O
after	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
(	O
left	O
ventricular	I:C0181598
assist	I:C0181598
device	I:C0181598
)	O
placement	B:C1533810
.	O

However	O
,	O
improvement	O
or	O
worsening	O
of	O
model	B:C3826979
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
and	O
how	O
those	O
changes	O
affect	O
outcomes	O
is	O
unknown	O
.	O

We	O
performed	O
a	O
retrospective	B:C0035363
analysis	I:C0035363
of	O
244	O
patients	O
implanted	O
with	O
a	O
continuous	O
flow	I:C0181598
(	I:C0181598
CF	I:C0181598
)	I:C0181598
LVAD	I:C0181598
.	O

We	O
performed	O
a	O
retrospective	O
analysis	I:C0035363
of	O
244	O
patients	O
implanted	B:C0184961
with	O
a	O
continuous	O
flow	I:C0181598
(	I:C0181598
CF	I:C0181598
)	I:C0181598
LVAD	I:C0181598
.	O

We	O
performed	O
a	O
retrospective	O
analysis	I:C0035363
of	O
244	O
patients	O
implanted	O
with	O
a	O
continuous	B:C0181598
flow	I:C0181598
(	I:C0181598
CF	I:C0181598
)	I:C0181598
LVAD	I:C0181598
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	B:C0184666
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	B:C3826979
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	B:C0021107
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	B:C0008902
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	B:C0008902
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	B:C0442739
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	B:C4084902
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	B:C0442739
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	O
to	O
low	O
risk	O
)	O
.	O

Patients	O
were	O
dichotomized	O
at	O
admission	O
into	O
low	O
-	O
or	O
high	O
-	O
risk	O
categories	O
using	O
a	O
cutoff	O
of	O
model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
≥	O
19	O
,	O
and	O
they	O
were	O
reclassified	O
at	O
day	O
of	O
implant	O
forming	O
four	O
groups	O
:	O
Group	O
LL	O
(	O
remained	O
low	O
risk	O
)	O
,	O
LH	O
(	O
worsened	O
to	O
high	O
risk	O
)	O
,	O
HH	O
(	O
remained	O
high	O
risk	O
)	O
,	O
and	O
HL	O
(	O
improved	B:C0184511
to	O
low	O
risk	O
)	O
.	O

Patients	O
who	O
improved	B:C0184511
to	O
a	O
low	O
risk	O
(	O
group	O
HL	O
)	O
had	O
the	O
same	O
1	O
year	O
survival	O
as	O
those	O
that	O
remained	O
low	O
risk	O
(	O
group	O
LL	O
;	O
80	O
%	O
vs.	O
77	O
%	O
;	O
p	O
=	O
0.6	O
)	O
.	O

Patients	O
who	O
improved	O
to	O
a	O
low	O
risk	O
(	O
group	B:C0008902
HL	O
)	O
had	O
the	O
same	O
1	O
year	O
survival	O
as	O
those	O
that	O
remained	O
low	O
risk	O
(	O
group	O
LL	O
;	O
80	O
%	O
vs.	O
77	O
%	O
;	O
p	O
=	O
0.6	O
)	O
.	O

Patients	O
who	O
improved	O
to	O
a	O
low	O
risk	O
(	O
group	O
HL	O
)	O
had	O
the	O
same	O
1	O
year	O
survival	B:C2919552
as	O
those	O
that	O
remained	O
low	O
risk	O
(	O
group	O
LL	O
;	O
80	O
%	O
vs.	O
77	O
%	O
;	O
p	O
=	O
0.6	O
)	O
.	O

Patients	O
who	O
improved	O
to	O
a	O
low	O
risk	O
(	O
group	O
HL	O
)	O
had	O
the	O
same	O
1	O
year	O
survival	O
as	O
those	O
that	O
remained	B:C0442739
low	O
risk	O
(	O
group	O
LL	O
;	O
80	O
%	O
vs.	O
77	O
%	O
;	O
p	O
=	O
0.6	O
)	O
.	O

Patients	O
who	O
improved	O
to	O
a	O
low	O
risk	O
(	O
group	O
HL	O
)	O
had	O
the	O
same	O
1	O
year	O
survival	O
as	O
those	O
that	O
remained	O
low	O
risk	O
(	O
group	B:C0008902
LL	O
;	O
80	O
%	O
vs.	O
77	O
%	O
;	O
p	O
=	O
0.6	O
)	O
.	O

However	O
,	O
patients	O
who	O
were	O
initially	O
classified	B:C0008902
as	O
low	O
risk	O
and	O
worsened	O
to	O
a	O
high	O
risk	O
(	O
group	O
LH	O
)	O
had	O
a	O
survival	O
that	O
was	O
worse	O
than	O
those	O
that	O
were	O
consistently	O
high	O
risk	O
(	O
group	O
HH	O
;	O
55	O
%	O
vs.	O
10	O
%	O
;	O
p	O
=	O
0.01	O
)	O
.	O

However	O
,	O
patients	O
who	O
were	O
initially	O
classified	O
as	O
low	O
risk	O
and	O
worsened	B:C4084902
to	O
a	O
high	O
risk	O
(	O
group	O
LH	O
)	O
had	O
a	O
survival	O
that	O
was	O
worse	O
than	O
those	O
that	O
were	O
consistently	O
high	O
risk	O
(	O
group	O
HH	O
;	O
55	O
%	O
vs.	O
10	O
%	O
;	O
p	O
=	O
0.01	O
)	O
.	O

However	O
,	O
patients	O
who	O
were	O
initially	O
classified	O
as	O
low	O
risk	O
and	O
worsened	O
to	O
a	O
high	O
risk	O
(	O
group	B:C0008902
LH	O
)	O
had	O
a	O
survival	O
that	O
was	O
worse	O
than	O
those	O
that	O
were	O
consistently	O
high	O
risk	O
(	O
group	O
HH	O
;	O
55	O
%	O
vs.	O
10	O
%	O
;	O
p	O
=	O
0.01	O
)	O
.	O

However	O
,	O
patients	O
who	O
were	O
initially	O
classified	O
as	O
low	O
risk	O
and	O
worsened	O
to	O
a	O
high	O
risk	O
(	O
group	O
LH	O
)	O
had	O
a	O
survival	O
that	O
was	O
worse	B:C1457868
than	O
those	O
that	O
were	O
consistently	O
high	O
risk	O
(	O
group	O
HH	O
;	O
55	O
%	O
vs.	O
10	O
%	O
;	O
p	O
=	O
0.01	O
)	O
.	O

However	O
,	O
patients	O
who	O
were	O
initially	O
classified	O
as	O
low	O
risk	O
and	O
worsened	O
to	O
a	O
high	O
risk	O
(	O
group	O
LH	O
)	O
had	O
a	O
survival	O
that	O
was	O
worse	O
than	O
those	O
that	O
were	O
consistently	O
high	O
risk	O
(	O
group	B:C0008902
HH	O
;	O
55	O
%	O
vs.	O
10	O
%	O
;	O
p	O
=	O
0.01	O
)	O
.	O

Model	B:C3826979
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	B:C0008902
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	B:C0035648
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	B:C0683956
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	B:C0034975
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	B:C0008902
and	O
2	O
.	O

Model	O
for	I:C3826979
end	I:C3826979
-	I:C3826979
stage	I:C3826979
liver	I:C3826979
disease	I:C3826979
reclassification	O
after	O
adjusting	O
for	O
commonly	O
attributed	O
risk	O
factors	I:C0035648
remained	O
an	O
independent	O
predictor	O
for	O
mortality	O
,	O
including	O
patients	O
classified	O
as	O
Interagency	O
Registry	I:C0034975
for	I:C0034975
Mechanically	I:C0034975
Assisted	I:C0034975
Circulatory	I:C0034975
Support	I:C0034975
(	I:C0034975
INTERMACS	I:C0034975
)	I:C0034975
1	O
and	O
2	B:C0008902
.	O

In	O
conclusion	O
,	O
our	O
MELD	B:C1718072
score	I:C1718072
reclassification	O
is	O
an	O
independent	O
and	O
powerful	O
predictor	O
of	O
mortality	O
in	O
patients	O
undergoing	O
LVAD	O
implantation	I:C0397130
.	O

In	O
conclusion	O
,	O
our	O
MELD	O
score	I:C1718072
reclassification	B:C0008902
is	O
an	O
independent	O
and	O
powerful	O
predictor	O
of	O
mortality	O
in	O
patients	O
undergoing	O
LVAD	O
implantation	I:C0397130
.	O

In	O
conclusion	O
,	O
our	O
MELD	O
score	I:C1718072
reclassification	O
is	O
an	O
independent	O
and	O
powerful	O
predictor	B:C0683956
of	O
mortality	O
in	O
patients	O
undergoing	O
LVAD	O
implantation	I:C0397130
.	O

In	O
conclusion	O
,	O
our	O
MELD	O
score	I:C1718072
reclassification	O
is	O
an	O
independent	O
and	O
powerful	O
predictor	O
of	O
mortality	O
in	O
patients	O
undergoing	O
LVAD	B:C0397130
implantation	I:C0397130
.	O

